Anti-RANKL therapy--implications for the bone-vascular-axis in CKD? Denosumab in post-menopausal women with low bone mineral density
- PMID: 16702197
- DOI: 10.1093/ndt/gfl245
Anti-RANKL therapy--implications for the bone-vascular-axis in CKD? Denosumab in post-menopausal women with low bone mineral density
Comment on
-
Denosumab in postmenopausal women with low bone mineral density.N Engl J Med. 2006 Feb 23;354(8):821-31. doi: 10.1056/NEJMoa044459. N Engl J Med. 2006. PMID: 16495394 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
